Margaret Purden

Suggest Changes
Learn More
OBJECTIVE Little is known about the day-to-day experiences of patients and their support persons during the course of epoprostenol treatment for pulmonary arterial hypertension (PAH). The study(More)
BACKGROUND Patients with heart failure (HF) in the community represent a large and growing patient population whose complex care requires implementation of innovative care modalities. The Centre(More)